STREAMD is pleased to announce that the results of our randomized, controlled clinical trial have been published in the Journal of Bone and Joint Surgery. The study evaluated the impact STREAMD had on patients recovering from total hip and knee replacement.
More than ever, a focus on engaging the patients is utmost important. Given the link between reimbursement and successful patient engagement, providers must encourage patients to use portals and interact with their health information. However, as we have discussed previously, the have been several obstacles in successfully utilizing these methods. A focus is now on more simple technology options that patients can access without the startup and maintenance effort required of previously trialed portals. StreaMD is dedicated to researching and providing these opportunities and services.
Read MoreAs clinicians consider implementing mobile apps into their clinical practice, they must be aware of these inherent shortcomings. Developers of patient engagement platforms should focus on patient and provider usability first, and then consider what data is required from the patient to ensure a successful clinical outcome.
Read MoreIn earlier generations, healthcare providers were prohibited from advertising their services. Word of Mouth was considered the sole marketing tool that would drive a healthcare practice. As we enter 2018, physicians have utilized hundreds of marketing/advertising resources. However, one thing has not changed much over time, and that is the value of word-of-mouth marketing. This just happens to take multiple forms these days! One of the most popular sources of word-of-mouth marketing in this information age, is front and center on online review sites.
Read MoreOn May 11-13, 2017, the American Academy of Orthopaedic Surgeons (AAOS) and the Orthopedic Research Society (ORS) held their inaugural Innovation and Entrepreneurship Symposium in Rosemont, titled Translating Orthopaedic Technologies into Clinical Practice: Pathways from Novel Idea to Improvements in Standard of Care.
Read MoreIf we were to ask you what medication or treatment has recently been referred to as:
“The blockbuster drug of the century”
“The holy grail of healthcare”
“The evolution of this will be what shape the future of healthcare”
“No other intervention will have as much of an impact on improving quality of care and reducing healthcare costs”
Read More